Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 10/20 | 0.91 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 7/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Ethylhexanoic Acid SCHEMBL8062070 | 1.00 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL9418221 | 0.98 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL2478480 | 0.98 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL6741710 | 0.98 | CA2 (0.88) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL23802667 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL9147740 | 0.95 | CA2 (1.00) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL305226 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL20582677 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL21569275 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR | |
| 2-Ethylhexanoic Acid SCHEMBL2400572 | 0.95 | CA2 (0.91) | CA2MAPK1CA1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101997-A1 | CHEMICAL BINDING OF SURFACE POLYMER TO EPOXY MATERIAL | YIELD ENGINEERING SYSTEMS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122039174-A | High-stability sulfuric acid-hydrogen peroxide copper plating stripping agent and preparation method and application thereof | 扬州纳力新材料科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260090240-A1 | DISPLAY PANEL AND MANUFACTURING METHOD THEREFOR, AND DISPLAY APPARATUS | Shanghai Tianma Microelectronics Co, Ltd. (CN) | 2026-03-26 | — | — | US | claimed |
| EP-4045544-B1 | SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION | BASF COATINGS GMBH (DE) | 2026-03-18 | — | — | EP | claimed |
| CN-121572687-A | Layered flame-retardant polyurethane composite material and preparation method thereof | 深圳市力信陆南实业有限公司 | 2026-02-27 | — | — | CN | claimed |
| US-12534561-B2 | Controlled radical polymerization | BASF COATINGS GMBH (DE) | 2026-01-27 | — | — | US | claimed |
| US-12515964-B2 | Tin oxide forming composition | LG CHEM, LTD. (KR) | 2026-01-06 | — | — | US | claimed |
| CN-120059585-A | Self-cleaning paint for bathroom products and preparation method thereof | 厦门雅泽工贸有限公司 | 2025-05-30 | — | — | CN | claimed |
| EP-4036059-B1 | COMPOSITION FOR FORMING TIN OXIDE | LG CHEMICAL LTD (KR) | 2025-02-19 | — | — | EP | claimed |
| CN-119455099-A | Preparation method of antithrombotic small-caliber artificial blood vessel with double-layer structure | 南通大学 | 2025-02-18 | — | — | CN | claimed |
| EP-0946624-B1 | BIODEGRADABLE TARGETABLE MICROPARTICLE DELIVERY SYSTEM | AVENTIS PASTEUR (CA) | 2003-04-02 | — | — | EP | claimed |
| EP-0662103-B1 | DEGRADABLE POLYMER COMPOSITION | BIOPAK TECHNOLOGY LTD (US) | 2002-11-27 | — | — | EP | claimed |
| US-5955609-A | Trimer catalyst system for aliphatic and aromatic isocyanates | BAYER CORPORATION (US) | 1999-09-21 | — | — | US | claimed |
| EP-0646608-B1 | POLYISOCYANATE, BLOCKED POLYISOCYANATE AND COATING COMPOSITION | ASAHI CHEMICAL IND (JP) | 1999-04-21 | — | — | EP | claimed |
| EP-0637600-B1 | New polyester polyurethanes, their preparation process, pseudo-latex prepared from these polyester polyurethanes and their use in cosmetic compositions | OREAL (FR) | 1997-04-09 | — | — | EP | claimed |
| EP-0500397-B1 | Method of producing transparent zinc oxide films | HONJO CHEM KK (JP) | 1996-09-18 | — | — | EP | claimed |
| EP-0539274-B1 | Method for the synthesis of aldehydes and of their derivatives | RHONE POULENC CHIMIE (FR) | 1996-04-10 | — | — | EP | claimed |
| EP-0129069-B1 | PROCESS FOR BONDING NON-POLAR OR HIGHLY CRYSTALLINE RESIN SUBSTRATS TO EACH OTHER OR TO ANOTHER MATERIAL | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1991-08-21 | — | — | EP | claimed |
| US-4377156-A | Solar collectors and process for the manufacture thereof | SCHELZIG MANFRED (DE) | 1983-03-22 | — | — | US | claimed |
| US-4153586-A | WATER SOLUBILITY | PPG INDUSTRIES, INC. (US) | 1979-05-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534561-B2 | Controlled radical polymerization | TST, G6PD, PROC | CA2 1635/4885MAPK1 1586/4885CA1 2303/4885 |
| US-20260090240-A1 | DISPLAY PANEL AND MANUFACTURING METHOD THEREFOR, AND DISPLAY APPARATUS | HTR3D, FZD7, OCIAD2 | CA2 4687/4885MAPK1 4422/4885CA1 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.